Speaker Fees for Educational Lecture from Sobi - Swedish Orphan Biovitrum Ltd (UK). £1120. Limitations on the talk were that I could not mention specific medicines by name and had to remove a slide talking about structure of EHL Factor 8 and 9 molecules.
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Co-Investigator on British Heart Foundation Project Grant: £236,336. Principle Investigator on National Institute for Health & Care Research Biomedical Research Centre Public Involvement Fund: £300.
£100- £1000
£200 for being on a panel at an Astra Zeneca sponsored symposium as part of the 'Let's Talk Clots' event run by Thrombosis UK. Talk was themed around use of DOACs and how to reverse them if bleeding. Included information on PCC and Andexanet Alfa
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
£88,000 (PI) AstraZeneca. RAPIDO: A HaemSTAR-led UK national audit of the use of Reversal Agents in Patients antIcoagulated with Direct Oral anticoagulants. £10,000 (PI) Dudley Leukaemia Unit Appeal Fund. RAPIDO: A HaemSTAR-led UK national audit of the use of Reversal Agents in Patients antIcoagulated with Direct Oral anticoagulants.
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.